
The pre-seed round was backed by Antler Nordics.

The Series B was led by Define Ventures, with support from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.

The round was led by Schroders Capital, with participation from General Catalyst and Lightspeed Venture Partners.